Document is current
Any future updates will be listed below
-
Authors
Cabrera, Roberto
Fernández-Barat, Laia
Motos, Anna
López-Aladid, Rubén
Vázquez, Nil
Panigada, Mauro
Álvarez-Lerma, Francisco
López, Yuly
Muñoz, Laura
Castro, Pedro
Vila, Jordi
Torres, Antoni
-
Funding
Funding for this research was provided by:
Instituto Científico Pfizer (WI173058)
Ciberes (CB 06/06/0028)
EUROPE ASPIRE (award 2011)
ICREA Academy Award
- License Information
-
More Information
Article History
Received: 4 October 2019
Accepted: 13 January 2020
First Online: 28 February 2020
Ethics approval and consent to participate
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. Hospital Clinic ethical committee reference number: 2012/7927.
: Not applicable.
: A. Torres has received grants from MedImmune, Cubist, Bayer, Theravance, and Polyphor and personal fees as Advisory Board member from Bayer, Roche, The Medicines CO, and Curetis. He has received personal speaker’s bureau fees from GSK, Pfizer, Astra Zeneca, and Biotest Advisory Board, unconnected to the study submitted here.
